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The arachidonic acid metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) regulates
renal function, including changes in glomerular function evoked during tubuloglomerular
feedback (TGF). This study describes the cellular actions of 20-HETE on cultured
podocytes, assessed by whole-cell recordings from cultured podocytes combined with
pharmacological and cell-biological manipulations of cells. Bath superfusion of 20-HETE
activates cationic currents that are blocked by the pan-TRP blocker SKF-96365 and
by 50µM La3+, and which are attenuated after siRNA knockdown of TRPC6 subunits.
Similar currents are evoked by a membrane-permeable analog of diacylgycerol (OAG),
but OAG does not occlude responses tomaximally-activating concentrations of 20-HETE
(20µM). Exposure to 20-HETE also increased steady-state surface abundance of
TRPC6 subunits in podocytes as assessed by cell-surface biotinylation assays, and
increased cytosolic concentrations of reactive oxygen species (ROS). TRPC6 activation
by 20-HETE was eliminated in cells pretreated with TEMPOL, a membrane-permeable
superoxide dismutase mimic. Activation of TRPC6 by 20-HETE was also blocked when
whole-cell recording pipettes contained GDP-βS, indicating a role for either small or
heterotrimeric G proteins in the transduction cascade. Responses to 20-HETE were
eliminated by siRNA knockdown of podocin, a protein that organizes NADPH oxidase
complexes with TRPC6 subunits in this cell type. In summary, modulation of ionic
channels in podocytes may contribute to glomerular actions of 20-HETE.
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INTRODUCTION
Podocytes are terminally differentiated multipolar cells that cover the outer surface of the
glomerular capillary and form the final barriers for glomerular filtration. Changes in podocyte
ultrastructure often occur in response to glomerular injuries and in a variety of disease processes. If
injuries are sustained, and if sufficient numbers of podocytes detach or die, the entire nephron
will be lost (Kim et al., 2001; Kriz and LeHir, 2005). Primary podocyte diseases have multiple
etiologies. Adult-onset familial forms of focal and segmental glomerulosclerosis (FSGS) occur with
an autosomal dominant mode of inheritance in patients with mutations in the gene encoding
canonical transient receptor potential-6 (TRPC6) channels. Most of these mutations result in a
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gain of function when the encoded channels are assayed in
heterologous expression systems (Reiser et al., 2005; Winn
et al., 2005). Moreover, proteinuria and glomerulosclerosis were
observed in mice over-expressing wild-type or mutant TRPC6
channels in podocytes (Krall et al., 2010) or in mice with
podocyte-specific mutations in heterotrimeric G proteins that
lead to constitutive activation of TRPC6 (Wang et al., 2015).
Therefore, it is important to understand physiological signals that
regulate the activity of TRPC6 channels in podocytes.
TRPC6 channels are Ca2+-permeable cationic channels that
play a role in G protein-mediated signaling in diverse cell types.
Within the kidney, TRPC6 channel subunits are expressed in
mesangial cells and podocytes (Bouron et al., 2016; Ma et al.,
2016), and probably also in renovascular myocytes such as
those in the afferent arteriole (Salomonsson et al., 2010). Within
podocytes, TRPC6 channels are located in the cholesterol-rich
slit diaphragm domains of foot processes, as well as in major
processes, and in the cell body (Reiser et al., 2005; Huber et al.,
2006; Dryer and Reiser, 2010). TRPC6 channels in foot processes
are components of large super-complexes that include podocin,
nephrin, NADPH oxidases, phospholipases, and tyrosine kinases
(Reiser et al., 2005; Huber et al., 2006; Kanda et al., 2011;
Anderson et al., 2013; Kim et al., 2013; Kalwa et al., 2015;
Rinschen et al., 2016).
A substantial body of evidence has suggested important roles
for 20-hydroxyeicosatetraenoic acid (20-HETE) in renal function
and dysfunction. 20-HETE is the ω-hydroxylated metabolite
of arachidonic acid produced by a family of cytochrome P450
variants known as CYP4A and CYP4F (Roman, 2002). 20-HETE
evokes vasoconstriction of various microvessels (Zhao et al.,
2004) owing in part to increased Ca2+ influx into vascular
myocytes (Zhao et al., 2004; Yaghi and Sims, 2005). In addition
to its effects on renovascular smooth muscle, 20-HETE also
modulates ion transport in the proximal tubule (Dos Santos
et al., 2004) and thick ascending loop of Henle (Yu et al.,
2007). While it is generally believed that 20-HETE can function
as an intracellular second messenger underlying responses
to vasoconstrictors and during renal vascular autoregulation
(Hoopes et al., 2015), there is evidence that 20-HETE can be
stored and released from pre-glomerular renal microvessels,
potentially leading to effects on other renal cell types through
paracrine signaling mechanisms (Carroll et al., 1997; Croft et al.,
2000).
In vascular smooth muscle, 20-HETE has been reported to
cause activation of TRPC6 channels and to act synergistically
with exogenous diacylglycerol (DAG), the canonical lipid
activator of TRPC6 (Inoue et al., 2009). This induces
depolarization and activation of voltage-activated Ca2+
channels of myocytes leading to vasoconstriction and changes in
renal blood flow, for example during tubuloglomerular feedback
(TGF) (Ge et al., 2014). 20-HETE has also been implicated
in communications between vascular endothelial cells and
neighboring cells (Hilgers and De Mey, 2009). In this regard,
recent studies have also demonstrated that TGF induces a wave
of elevated cytosolic Ca2+ in extraglomerular mesangial cells
that propagates from cell to cell, eventually leading to Ca2+
influx in the most distant podocytes and contraction of the
entire glomerular tuft (Peti-Peterdi, 2006). Increases in podocyte
intracellular Ca2+ also occur in response to focal injuries, and
spread from one podocyte to several others (Burford et al., 2014).
In the present study we have examined modulatory effects of
20-HETE on the activity of TRPC6 channels in podocytes. In
contrast to vascular smooth muscle or many mesangial cells (Yu
et al., 1989; Hall et al., 2000), podocytes are non-excitable cells
(Dryer and Reiser, 2010), and Ca2+ influx is primarily mediated
by receptor-activated channels in the TRPC family (Ilatovskaya
et al., 2014). We now report that 20-HETE exposure increases the
steady-state surface expression of TRPC6 subunits and increases
cationic currents through TRPC6 channels in podocytes. The
actions of 20-HETE on podocyte TRPC6 channels appear to
be indirect, as they require generation of reactive oxygen
species (ROS) and activation of GTPases. These responses may
also depend on the local membrane environment as they are
eliminated following podocin knock-down.
MATERIALS AND METHODS
Drugs and Reagents
The pan-TRP channel inhibitor 1-[2-(4-methoxyphenyl)]-2-[3-
(4-meth-oxyphenyl)propoxy]ethyl-1H-imidazole hydrochloride
(SKF-96365), the ROS scavenger 1-oxyl-2,2,6,6-tetramethyl-
4-hydroxypiperidine (TEMPOL), and guanosine 5′-[β-
thio]diphosphate (GDP-βS) were obtained from Sigma.
20-HETE and 1-oleoyl-2-acetyl-sn-glycerol (OAG) were
purchased from Cayman Chemical Co.
Podocyte Cell Culture, ROS Assays,
Immunoblot Analysis, and siRNA
Procedures
An immortalized mouse podocyte cell line (MPC-5) originally
developed by Dr. Peter Mundel of Harvard Medical School
was maintained at 33◦ as described previously on collagen-
coated glass coverslips (Kim et al., 2008). Podocyte differentiation
and expression of podocyte markers were induced by removal
of γ-interferon and raising temperature to 37◦C for 14 days.
TRPC6 siRNA, podocin siRNA and non-targeting control siRNA
were transfected into differentiated MPC-5 cells after isolation
using Lipofectamine 3000TM (Invitrogen) in serum-reduced
medium according to the manufacturer’s directions (Anderson
et al., 2013). Electrophysiological and biochemical analyses
were carried out 24 h after transfection with siRNAs. Panels
of siRNAs were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA) that target three different unique sequences
within TRPC6 (catalog sc-42673) and podocin (sc-40860), and
a non-targeting control siRNA (sc-37007). This vendor uses a
proprietary system to develop siRNAs that target three different
and unique 9-25 nucleotide portions of the transcript of interest.
The oligonucleotides are supplied as an RNA duplex in solution.
The siRNA sequence of the antisense oligonucleotide strands
that knock down TRPC6 are:
5′UUAACAUUGAGGGAAUGACtt3′
5′UAAUCUUCUGAGCUCCUUGtt3′
5′UUCUAAUGAGCUCUGCUAGtt3′
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The antisense siRNA sequences used to knock down podocin
are:
5′AUCUUGGGCAAUGCUCUUCtt3′
5′AGUUGCUUCAAGUUCUUGCtt3′
5′UUGUUUGCCAACUUGAUACtt3′
Immunoblot analyses and cell-surface biotinylation assays
were carried out by standard methods as described in previous
studies (Kim et al., 2013). Rabbit anti-TRPC6 was obtained
from Alomone Laboratories (Jerusalem, Israel, catalog number
ACC-017) and rabbit anti-podocin was purchased from Santa
Cruz Biotechnology (catalog number sc-21009). The TRPC6
antibodies from Alomone Laboratories nearly always allow for
ready detection of TRPC6. However, in our experience, different
lots of the antibody vary considerably in their sensitivity and
therefore in the number of cells needed to obtain a robust
signal. The experiments in which electrophysiology was carried
out after TRPC6 or podocin knockdown experiments were
based on three different transfections on different days for each
siRNA. Immunoblots were analyzed by densitometry using
Image JTM software (Bethesda, MD). Graphs summarizing
those data are plotted as mean ± SD, since this is the preferred
method of showing data dispersion with a triplicate measures
in biochemical experiments. Steady-state intracellular ROS
levels of podocytes were estimated using the OxiSelect
fluorometric assay (Cell Biolabs, San Diego, CA) according
to the manufacturer’s instructions. In this assay, a cell-permeable
probe, 2′,7′-dichlorodihydrofluorescin diacetate is deacetylated
by cytosolic enzymes to yield a non-fluorescent product that
is trapped in the cytosol. In the presence of intracellular
ROS, this probe is oxidized to a fluorescent product, 2′,7′-
dichlorodihydrofluorescein (DCF), which is measured using
a fluorescent microplate reader at excitation and emission
wavelengths of 485 nm and 530 nm, respectively. These
measurements were repeated in three different cell culture
preparations exposed to 20-HETE or control medium.
Electrophysiology
Methods for conventional whole-cell recordings from podocytes
were carried out by standard methods that have been described
in detail previously (Anderson et al., 2013, 2014; Roshanravan
and Dryer, 2014). Recordings were made with an Axopatch 1D
amplifier (Molecular Devices) and analyzed using pClampTM v10
software (Molecular Devices). For analyses of currents through
TRPC6, the bath solution contained 150mM NaCl, 5.4mM
CsCl, 0.8mM MgCl2, 5.4mM CaCl2, and 10mM HEPES, pH
7.4. Pipette solutions contained 10mM NaCl, 125mM CsCl,
6.2mM MgCl2, 10mM HEPES, and 10mM EGTA, pH 7.2. The
presence of Cs+ in bath and pipette solutions, and the absence
of K+ in those solutions, precludes current flowing through
KCa1.1 channels that are also expressed in these cells (Kim
et al., 2008). The relatively high Ca2+ concentration in the bath
solution markedly increases stability of whole cell recordings.
In experiments on TRPC6, currents were periodically evoked
by 2.5-s ramp voltage commands (−80mV to +80mV) from
a holding potential of −40mV. Whole cell current amplitudes
were quantified at+80mV. Recording pipettes in all experiments
had resistances of 2–5 M, and it was possible to maintain stable
recordings while compensating up to 80% of this series resistance.
Statistical Analyses
Comparisons between multiple groups were carried out using
one-way ANOVA followed by Tukey’s HSD post hoc test using
online packages at www.vassarstats.net Comparisons between
two groups were carried out using Student’s unpaired t-test using
the same on-line resource. In all cases P < 0.05 was regarded as
significant. Data from electrophysiological experiments, in which
each group contained 6–12 cells, are presented as mean ± SEM.
Data from biochemical experiments, all of which were repeated
on three separate preparations of cells, are shown graphically as
mean± SD.
RESULTS
20-HETE Increases Currents through
TRPC6 Channels and Increases
Abundance of TRPC6 Subunits on the
Podocyte Cell Surface
In initial experiments, we exposed differentiated immortalized
mouse podocytes (MPC-5 cells) to 1µM 20-HETE by gravity-fed
bath superfusion during conventional whole-cell recordings in
which we periodically applied ramp voltage commands (−80mV
to +80mV over 2.5 s). About 1–2 min after the onset of
1µM 20-HETE application, we observed an increase in an
outwardly rectifying current observed during the voltage ramps.
This current was eliminated by subsequent exposure to either
10µM SKF-96365, a pan-TRP channel blocker (Figures 1A,C),
or by 50µM La3+, an ion that inhibits TRPC6 but not TRPC5
channels (Figures 1B,C) (Jung et al., 2003; Tian et al., 2010;
Anderson et al., 2014; Roshanravan and Dryer, 2014). This
last experiment was carried out because TRPC5 channels are
expressed in podocytes (Tian et al., 2010), although as yet
the factors that cause them to become active are not known.
Activation of currents in podocytes occurred at micromolar
concentrations of 20-HETE, with maximal effects occurring at
a nominal concentration of 10–20µM (Figure 1D). To further
assess whether 20-HETE-induced cationic currents require
TRPC6 channels, we transiently knocked down TRPC6 channels
using siRNAs that target TRPC6 (Figure 1E). Control cells were
transiently transfected with non-targeting siRNAs. We observed
that 20-HETE activation of TRPC6 channels was markedly
attenuated in the podocytes that were treated with TRPC6
siRNA, whereas 1µM 20-HETE increased currents in cells
treated with control siRNA (Figures 1F,G). Moreover, using cell-
surface biotinylation assays, we observed that exposure to 1µM
20-HETE evoked an increase in steady-state surface expression
of TRPC6 subunits (Figure 1H). Collectively these data indicate
that 20-HETE is capable of modulating endogenously expressed
TRPC6 channels of podocytes. We have previously shown
that currents with similar properties are activated by exposing
podocytes to a membrane-permeable diacylglycerol analog
(OAG) (Anderson et al., 2013; Kim et al., 2013). Here we
observed that 100µM OAG evoked an additional increase in
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FIGURE 1 | Currents activated by 20-HETE in cultured podocytes. (A) Examples of currents evoked by 2.5-s ramp voltage commands (−80mV to +80mV).
Trace to the left shows currents shortly after making whole-cell contact. Middle trace is from the same cell 3min after exposure to 1µM 20-HETE, and trace to the
right shows complete blockade of the current by SKF-96365. (B) Similar recording from a different cell showing complete block of 20-HETE-evoked current by 50µM
La3+. (C) Summary of results of this experiment (n = 10 cells per group). Data are presented as fold-increase over initial baseline current at +80mV. The differences in
(Continued)
Frontiers in Physiology | www.frontiersin.org 4 August 2016 | Volume 7 | Article 351
Roshanravan et al. 20-HETE and Podocyte TRPC6 Channels
FIGURE 1 | Continued
means were calculated by Tukey’s HSD post hoc test following one-way ANOVA. (D) Percentage of maximal current amplitudes at +80mV plotted vs. concentration
of 20-HETE. Note saturation of the response by 20µM 20-HETE. (E) Immunoblot analysis showing effects of non-targeting siRNA (con) and siRNA targeting TRPC6
on total abundance of TRPC6. A typical immunoblot is shown above graphical summary of experiments from three different transfections. Asterisk indicates P < 0.01
(unpaired t-test). (F) Examples of responses to 1µM 20-HETE in cells pre-treated with non-targeting (control) or TRPC6-targeting siRNA using procedures shown in
E. Note lack of response to 20-HETE after TRPC6 knockdown. (G) Summary of the results of the experiment in panel F (n = 6 cells per group). Asterisk indicates P <
0.05 (unpaired t-test). (H) Cell-surface biotinylation assays show that exposure to 1µM 20-HETE for 24 hr increases steady-state surface abundance of TRPC6.
Typical blots are shown on top of graphical summary of three repetitions of this experiment. Asterisk indicates P < 0.05 (unpaired t-test).
currents in podocytes after prior activation of TRPC6 by 20µM
20-HETE. The current observed in the presence of both lipids
was abolished by 50µM La3+ (Figures 2A,B). This pattern was
seen regardless of which lipid was applied first. Thus, superfusion
with 20µM 20-HETE increased current amplitudes even when
it was applied after a steady-state response to 100µM OAG was
achieved (Figures 2C,D). Application of 50µM La3+ abolished
the currents seen in presence of both lipids, regardless of which
lipid was applied first.
20-HETE Effects on Podocyte TRPC6
Channels Require ROS, G Protein
Activation, and Podocin
Studies from our laboratory and from several others have shown
that activation of podocyte TRPC6 channels by a variety of
modulators requires generation of ROS (Kim et al., 2012a,b,
2013, 2015; Liu et al., 2013, 2015; Anderson et al., 2014;
Ilatovskaya et al., 2014; Ma et al., 2016). Using a fluorescence
assay, we observed that exposure to 1µM 20-HETE for 24
h caused an increase in the bulk cytosolic concentration of
ROS (Figure 3A). In previous studies we have also shown that
NADPH oxidases occur as part of a much larger complex that
includes TRPC6 channels and podocin (Kim et al., 2013). Because
ROS concentration will increase quite rapidly within nanometers
of the sites where they are generated, it is likely that TRPC6
channels are exposed to relatively high concentrations of ROS
shortly after the onset of 20-HETE application. Consistent with
this, we observed that 1µM 20-HETE was no longer able to
activate currents in podocytes pre-treated with 10 mMTEMPOL,
a membrane-permeable superoxide dismutase mimic that causes
quenching of ROS (Wilcox, 2010) (Figures 3B–D). The actions
of 20-HETE on podocyte TRPC6 channels also require activation
of G proteins within the cell. This was ascertained in experiments
in which recording pipettes were filled with 50µM guanosine-
5′-O-(2-thiodiphosphate) (GDP-βS), which rapidly diffuses into
the cell and prevents activation of either heterotrimeric or small
GTPases (Eckstein et al., 1979; Kwong et al., 1993). We observed
that this procedure prevented activation of cationic currents
by 1µM 20-HETE, whereas normal responses to 20-HETE
were seen in recordings made in the same sessions and cell
preparations using normal pipette solutions (Figure 4).
Podocin organizes signaling complexes surrounding TRPC6
channels in podocyte foot processes. Therefore, we examined
whether transient podocin knockdown using siRNA affects
responses to 20-HETE (Figure 5). We observed that transfection
with siRNA targeting podocin caused a reduction in podocin
abundance compared to cells treated with non-targeting siRNA
(Figure 5A), whereas total TRPC6 abundance was normal or
close to normal in both groups (Figure 5B). As with our earlier
studies on diacylglycerol analogs (Kim et al., 2013), we observed
that activation of TRPC6 by 1µM 20-HETE did not occur after
podocin knockdown (Figures 5C–E).
DISCUSSION
Podocytes are terminally differentiatedmultipolar cells that cover
the external surface of glomerular capillaries, and form an
essential component of the glomerular filtration barrier. While it
was once thought that podocytes and their slit diaphragms were
simple static barriers, there is growing evidence that podocytes
react and adapt to acute changes in glomerular filtration
and hyperfiltration (Peti-Peterdi, 2006; Salmon et al., 2007).
Podocytes are subjected to substantial mechanical forces owing
to the net hydrodynamic filtration pressure, and shear forces
produced by fluids flowing through slit diaphragms and the sub-
podocyte space (Kriz et al., 2013; Kriz and Lemley, 2015). As a
result, podocytes are at constant risk of detachment. Indeed, a
podocytes tend to detach before dying, as viable podocytes can be
detected in urine (Vogelmann et al., 2003). There is considerable
evidence that loss of a certain threshold number of podocytes
triggers a series of events that eventually leads to loss of the entire
nephron (Kim et al., 2001; Kriz and LeHir, 2005; Macconi et al.,
2006). Nevertheless, podocytes are normally able to maintain the
stability of slit diaphragms in the face of large acute distending
forces affecting the glomerular capillary (Kriz et al., 1994). The
mechanisms whereby they accomplish this are complex and
not well understood but certainly entail marked changes in
cell cytoskeletal organization and morphology of foot processes.
There is evidence that the foot process cytoskeleton is regulated
in part by Ca2+-dynamics within podocytes (Tian et al., 2010;
Vassiliadis et al., 2011). TRPC6 channels are major regulators of
Ca2+ dynamics in podocytes (Dryer and Reiser, 2010; Tian et al.,
2010), and normally occur at slit diaphragms in complex with
other key slit diaphragm proteins (Reiser et al., 2005; Huber et al.,
2006; Anderson et al., 2013). Moreover, there is now substantial
evidence that while activation of TRPC6 channels may contribute
acutely to normal physiological processes (Kim et al., 2012a),
sustained and excessive activation of TRPC6 eventually leads
to glomerular pathologies (Reiser et al., 2005; Winn et al.,
2005; Krall et al., 2010; Wang et al., 2015). Consequently, it is
important to identify physiologically occurring factors that can
cause TRPC6 channels in podocytes to become active.
In the present study we show that 20-HETE increases current
flowing through podocyte TRPC6 channels, as has been observed
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FIGURE 2 | Effects of 20-HETE in presence and absence of a membrane-permeable analog of diacylgycerol (OAG). (A) Examples of currents from a single
podocyte shortly after making whole-cell contact; after exposure to 20µM 20-HETE; and then after 100µM OAG was added to the superfusate. At the end of the
experiment, 50µM La3+ was added to the superfusate, which brought currents back to the original baseline. Note that OAG increased currents even in presence of a
maximally active concentration of 20-HETE. (B) Summary of the results of this experiment (n = 5 cells per group). Data were analyzed by Tukey’s HSD test following
one-way ANOVA. (C) Similar experiment to the one shown in (A), except that cells were first exposed to 100µM OAG and then exposed to the combination of lipids.
(D) Summary of results of the experiment shown in (C). The responses to OAG and 20-HETE are approximately additive.
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FIGURE 3 | Role of ROS in actions of 20-HETE on TRPC6. (A) Increased bulk cytosolic ROS concentration in podocytes as measured using fluorescence assay
in control cells and cells exposed to 1µM 20-HETE for 24 h. Asterisk indicates P < 0.01 (unpaired t-test). (B) Traces showing responses to 1µM 20-HETE. (C)
Example of response to 1µM 20-HETE in cell that had been pre-treated with 10mM TEMPOL, an agent that quenches ROS. (D) Summary of the results of this
experiment (n = 6 cells per group). Note complete inhibition of response to 20-HETE in cells pretreated with TEMPOL (asterisk indicates P < 0.05, unpaired t-test).
previously in vascular smooth muscle (Inoue et al., 2009). A
more novel observation in this study is that the effects of 20-
HETE on the TRPC6 channels of podocytes are indirect, as we
observed that modulation of TRPC6 requires generation of ROS
and activation of GTPases. Moreover, 20-HETE activation of
TRPC6 was blocked by podocin knockdown. A substantial body
of evidence now indicates that endogenously formed 20-HETE
plays multiple roles in the regulation of renal function, especially
within the pre-glomerular vasculature (Zou et al., 1994; Ge et al.,
2014).
In this study we have confirmed an earlier observation that
20-HETE increases the generation of ROS in podocytes (Eid
et al., 2009). A similar effect has been observed in myocytes
from cerebral arteries (Gebremedhin et al., 2014), as well as
in cardiac myocytes where it occurs secondary to activation
of NADPH oxidases (Zeng et al., 2010). Previous studies have
shown that ROS is a powerful mediator of TRPC6 gating and
trafficking (Graham et al., 2010; Ding et al., 2011) although
it is notable that the role of ROS on TRPC6 appears to vary
according to cell type (Graham et al., 2011; Bouron et al., 2016).
The role of ROS in modulation of podocyte TRPC6 channels is
summarized schematically in Figure 6. ROS generation appears
to occur upstream of the actions of 20-HETE on TRPC6, as with
DAG analogs, at least in this particular cell type (Kim et al.,
2013). Previous studies have shown that ROS generation through
NADPH oxidases is required for modulation of TRPC6 channels
in podocytes in response to several different stimuli, including
insulin (Kim et al., 2012a), angiotensin II (Anderson et al., 2014;
Ilatovskaya et al., 2014), P2Y receptor agonists (Roshanravan and
Dryer, 2014) and syndecans (Kim et al., 2015). The small GTPase
Rac1 is required for activation of several NADPH oxidases,
including NOX2 and NOX4 (Bedard and Krause, 2007). This
by itself may suffice to explain why GDP-βS is also able to
block TRPC6 activation by 20-HETE, although this procedure
may affect other processes as well. In addition, the active form
of NOX2 assembles as part of a complex with podocin and
TRPC6 (Kim et al., 2013), and we have also detected interactions
between podocin and NOX4 (unpublished data). These steps
may be obligatory for any lipid-mediated transduction cascades
that converge on TRPC6 channels in podocyte foot processes.
As summarized in Figure 6, in the acute absence of podocin,
formation of higher-order complexes that allow ROS generation
in the immediate vicinity of TRPC6 channels are not possible.
It is certainly possible that over time, some other member of
the podocin/stomatin family of hairpin loop cholesterol binding
proteins can take over this function.
Various diacylglycerols such as OAG can also activate TRPC6,
indeed this was the first class of molecules ever shown to activate
these channels (Hofmann et al., 1999). It is notable that the
actions of relatively high concentrations of 20-HETE (at 20µM)
and OAG (at 100µM) produced at least additive activation of
endogenous podocyte TRPC6 channels, and the responses to
these lipids do not occlude. This is consistent with previous
studies in vascular smooth muscle, which have shown that 20-
HETE enhances OAG-induced activation of TRPC6 channels in
cells and excised patches (Inoue et al., 2009). In this regard, it is
clear that 20-HETE and OAG can activate TRPC6 channels in a
membrane-delimited fashion (Hofmann et al., 1999; Basora et al.,
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FIGURE 4 | G protein signaling is required for 20-HETE modulation of
podocyte TRPC6 channels. (A) Trace showing increased current evoked by
1µM 20-HETE recorded with normal pipette saline. (B) Recording from
different cell made with pipette containing 50µM GDP-βS. Note that 20-HETE
does not evoke a change in current under those conditions. (C) Summary of
fold increase in current at +80 mV evoked by 20-HETE compared to baseline
in absence or presence of GDP-βS in recording pipette. Asterisk indicates P <
0.05 (unpaired t-test, n = 15 cells per group).
2003; Inoue et al., 2009). In podocytes this additive effect was seen
even at the top of the dose-response curves for both lipids. This
suggests that the mechanisms of the lipids diverge at some level,
even though the actions of both lipids are dependent on podocin
and ROS generation. The simplest possibility is that 20-HETE
and OAG act on different subpopulations of TRPC6 within the
cell. In this regard, we observed here that 20-HETE increased
the steady-state surface expression of TRPC6 in podocytes.
Previous studies have shown that rapid TRPC6 exocytosis also
occurs during Gq mediated signaling, especially in cholesterol-
rich membrane domains, and that this step preceded Ca2+ entry
(Cayouette et al., 2004). Therefore, it is also possible that 20-
HETE rapidly increases surface expression of TRPC6 channels
which are then available for activation by OAG. Alternatively it is
possible that the 20-HETE and OAG induce processes that act on
different domains of the same TRPC6 channels. This later model
is consistent with data obtained from vascular smooth muscle
cells, in which 20-HETE andOAG appear to act at least additively
in a membrane-delimited fashion in excised membrane patches
(Inoue et al., 2009).
Perspectives
Many studies on 20-HETE have framed their results in terms
of a second-messenger type action for this lipid (Roman, 2002).
However, there is now abundant evidence that 20-HETE can be
stored and released, and can be excreted into urine, especially
after exposure to angiotensin II (Carroll et al., 1997; Alonso-
Galicia et al., 2002). Moreover, circulating 20-HETE appears to be
increased in patients with atherosclerotic disease (Schuck et al.,
2013). These observations raise the possibility that 20-HETE
produces paracrine effects within glomeruli. As yet, no surface
receptor for 20-HETE has been identified, and may not exist,
but it is worth noting that other hydroxyeicosatetraenoic acids
exert their effects in part through activation of specific G-protein
coupled receptors, such as the OXE receptor and GPR31 (Powell
and Rokach, 2015). Therefore, it remains possible that 20-HETE
could cause modulation of podocyte TRPC6 channels through
multiple mechanisms.
In general, 20-HETE has been considered renoprotective,
in part because it is thought to reduce transmural pressure
gradients across glomerular capillaries secondary to constriction
of afferent arterioles (Fan et al., 2015). It clearly has actions
in other renal cell types, and we show here that it causes
activation of TRPC6 in podocytes. The physiological role of
TRPC6 in podocytes is not fully understood but may play a role
in allowing podocytes to acutely adapt to various mechanical
and paracrine stimuli. In this regard, there is evidence that
TRPC6 channels are acutely protective in an inflammatory
milieu, for example during complement-mediated glomerular
disease (Kistler et al., 2013). The underlying glomerular capillary
pulsates, and there are substantial shear forces associated with
hydrodynamic flow across the cell surface. The sub-podocyte
space is also subjected to expansile forces. Collectively, these
forces tend to promote detachment of podocytes. Bioactive
agents such as angiotensin II and ATP can function as
endocrine and/or paracrine signals and may lead to increased
production of 20-HETE within podocytes, and it is possible
that this plays an acute role in allowing podocytes to adapt
to hyperfiltration. We have previously proposed that insulin
actin in part through podocyte TRPC6 channels may also
play a role in preparing glomeruli for hydrodynamic changes
that occur as the kidney handles a glucose load (Kim et al.,
2012a).
On the other hand, processes that are adaptive over short
periods of time can become pathological if they are abnormally
sustained. There are several lines of evidence that sustained
activation of TRPC6 channels in podocytes contributes to foot
process effacement and glomerulosclerosis (Reiser et al., 2005;
Winn et al., 2005; Krall et al., 2010; Wang et al., 2015).
There is also evidence that effacement itself, at least in the
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FIGURE 5 | Podocin is required for 20-HETE modulation of podocyte TRPC6 channels. (A) Representative immunoblots showing podocin abundance in cells
treated with non-targeting siRNA and siRNA targeting podocin. Bar graph summarizing three repetitions of this experiment is shown to the right. Asterisk indicates P
< 0.01 (unpaired t-test). (B) Treatment with siRNA targeting podocin does not affect TRPC6 abundance. Representative immunoblots are shown to the left, and bar
graph summarizing results from three different transfections is shown to the right. (C) Representative trace showing increased currents in podocyte evoked by 1µM
20-HETE in cell treated with non-targeting siRNA. (D) Typical response to 1µM 20-HETE in cell treated with siRNA targeting podocin. (E) Summary of fold increase in
current at +80 mV evoked by 1µM 20-HETE compared to baseline in cells treated with non-targeting siRNA (control) and siRNA targeting podocin. Asterisk indicates
P < 0.05 (unpaired t-test, n = 6 cells per group).
acute phase, is a mechanism that podocytes under stress use
to prevent detachment (Kriz and Lemley, 2015). Given this,
there may be conditions, for example during hyperglycemia or
when glomerular hypertension is already well developed, when
inhibition of 20-HETE synthesis or its actions on TRPC6 could
be beneficial.
A limitation of this study is that analyses were carried out
on a differentiated mouse podocyte cell line. This cell line has
been widely used in the literature on experimental nephrology,
and the cells express many of the key podocyte markers and
regulatory molecules, including podocin, synaptopodin, and
nephrin. However, their morphology is different from that of
podocytes in situ which maintain contact with a glomerular
capillary. It is therefore possible that certain signaling cascades
no longer maintain their normal spatial relationships, and
there are almost certainly differences in gene expression
between the immortalized podocytes and native podocytes within
glomeruli.
CONCLUSIONS
We have shown that exogenous 20-HETE causes activation of
podocyte TRPC6 channels. It is possible that this plays a role in
regulation of glomerular function, for example during TGF, or
Frontiers in Physiology | www.frontiersin.org 9 August 2016 | Volume 7 | Article 351
Roshanravan et al. 20-HETE and Podocyte TRPC6 Channels
FIGURE 6 | Schematic diagrams suggesting mechanisms surrounding 20-HETE modulation of TRPC6 in podocytes. (A) In many cell types, 20-HETE can
be produced during G protein coupled signaling cascades, for example by G protein coupled receptor (GPCR) pathways activated by angiotensin II. In foot processes
and in immortalized podocyte cell lines, a population of TRPC6 channels is part of a larger complex organized by podocin, a cholesterol-binding hairpin loop protein.
In the presence of podocin, NOX enzymes are able to assemble in close proximity to TRPC6 channels, including for example formation of a ternary complex between
gp91phox and TRPC6 (Kim et al., 2013). This can lead to highly localized and rapid generation of ROS within the immediate vicinity of the channels. The effect of
20-HETE on podocyte TRPC6 channels requires G proteins, which may reflect a requirement of Rac activation for NOX2 or NOX4 activation (Bedard and Krause,
2007), or in other aspects of TRPC6 trafficking to the cell surface. (B) Data from many laboratories indicate that TRPC6 channels become active in presence of ROS,
most likely though a combination of increased open probability of surface channels and increased steady-state localization at the cell surface.
during response to mediators such as angiotensin II. It may also
play a role in pathological changes that occur in podocytes under
various conditions.
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